ANS014004

· Avistone Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ANS014004, covering 2025-12-16 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]